The Egyptian Drug Authority has identified an advertisement violation by the Saudi German Hospital in Egypt. The hospital posted an ad on Facebook on August 12, 2026, promoting a product called "Arthrosamid injection," which is registered with the authority. The ad claimed the product as a "non-surgical alternative to knee replacement." The authority's monitoring and public reports led to the discovery of the violation.
The Egyptian Drug Authority emphasized that the advertisement contains misleading marketing claims that could lead to misuse of the product and harm to citizens. The authority is responsible for regulating and monitoring to protect public health. The product in question is registered with the authority, but the advertisement's claims are deemed misleading.
The authority clarified that including a product or advertisement in the list of violations represents its regulatory and supervisory stance based on verified facts at the time of publication. This does not constitute a judicial ruling. The authority advises the public not to follow unknown advertisements and to verify information through official sources before using any medical or pharmaceutical product.
The Egyptian Drug Authority urged citizens to report any violations through available channels, such as the provided link, QR code, or hotline 15301. The authority assured that all reports and information received are handled confidentially and with full protection for the reporters. The authority is committed to protecting public health and safety.
The Saudi German Hospital in Egypt promoted the product with a misleading advertisement, which was detected through the authority's monitoring and public reports. The hospital's advertisement claimed the product was a non-surgical alternative to knee replacement. The authority took swift action to address the violation.
The Egyptian Drug Authority plays a crucial role in regulating and monitoring pharmaceutical products and advertisements in Egypt. The authority's efforts aim to protect public health and safety by ensuring that products and advertisements meet regulatory standards. The authority's hotline and reporting channels are available for the public to report any violations or concerns.
The authority's identification of the advertisement violation by the Saudi German Hospital in Egypt highlights its commitment to enforcing regulations and protecting public health. The authority will continue to monitor and take action against any violations to ensure the safety and well-being of Egyptian citizens.
Key points
- The Egyptian Drug Authority detected an advertisement violation by the Saudi German Hospital in Egypt for promoting an unlicensed product.
- The authority advises the public to verify information through official sources before using any medical or pharmaceutical product.
- The authority provides channels for reporting violations, including a hotline and QR code.
